Description
IMMUCOR TEST SUPPLIES
First action · last action
2021-10-01 · 2026-02-23
Transactions
13
First transaction's obligation
$99,734
Base + all options value (sum of deltas)
$797,250
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70110
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 13 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2021-10-01+$99,734= $99,734
- Mod P000012021-11-07+$49,238= $148,971
- Mod P000022022-10-01+$148,971= $297,943
- Mod P000052023-09-29+$5,343= $303,286
- Mod P000032023-10-01+$148,971= $452,257
- Mod P000062023-11-03+$12,475= $464,732
- Mod P000072023-12-14-$13,760= $450,972
- Mod P000082024-10-01+$148,971= $599,943
- Mod P000092024-10-29+$28,819= $628,762
- Mod P000102025-07-18-$1,737= $627,024
- Mod P000112025-09-29-$7,875= $619,149
- Mod P000122025-10-01+$177,079= $796,227
- Mod P000132026-02-23+$1,022= $797,250
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2021-10-01 | +$99,734 | $99,734 | IMMUCOR TEST SUPPLIES |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2021-11-07 | +$49,238 | $148,971 | IMMUCOR TEST SUPPLIES INCREASE IN QTY OF TEST SUPPLIES |
| Mod P00002· EXERCISE AN OPTION | 2022-10-01 | +$148,971 | $297,943 | IMMUCOR TEST SUPPLIES EXERCISE OPTION YEAR 1 |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-09-29 | +$5,343 | $303,286 | IMMUCOR TEST SUPPLIES EXERCISE OPTION YEAR 1 |
| Mod P00003· EXERCISE AN OPTION | 2023-10-01 | +$148,971 | $452,257 | IMMUCOR TEST SUPPLIES EXERCISE OPTION YEAR 1 |
| Mod P00006· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-11-03 | +$12,475 | $464,732 | IMMUCOR TEST SUPPLIES EXERCISE OPTION YEAR 1 |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2023-12-14 | −$13,760 | $450,972 | IMMUCOR TEST SUPPLIES EXERCISE OPTION YEAR 1 |
| Mod P00008· OTHER ADMINISTRATIVE ACTION | 2024-10-01 | +$148,971 | $599,943 | IMMUCOR TEST SUPPLIES EXERCISE OPTION YEAR 1 |
| Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2024-10-29 | +$28,819 | $628,762 | IMMUCOR TEST SUPPLIES |
| Mod P00010· OTHER ADMINISTRATIVE ACTION | 2025-07-18 | −$1,737 | $627,024 | IMMUCOR TEST SUPPLIES |
| Mod P00011· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-09-29 | −$7,875 | $619,149 | IMMUCOR TEST SUPPLIES |
| Mod P00012· EXERCISE AN OPTION | 2025-10-01 | +$177,079 | $796,227 | IMMUCOR TEST SUPPLIES |
| Mod P00013· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-02-23 | +$1,022 | $797,250 | IMMUCOR TEST SUPPLIES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI JA87HT8KP2M2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0379 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $671,956 | FY2026 |
| 36C25626P0989 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $24,200 | FY2026 |
| 36C24126N0746 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $2,961 | FY2026 |
| 36C24126N0753 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $89,895 | FY2026 |
| 36C24126N0747 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $127,637 | FY2026 |
| 36C24126N0748 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $13,031 | FY2026 |
Other recipients under 6640 from 249-NETWORK CONTRACT OFFICE 9 (36C249) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24926P0515 | BRANCH MEDICAL LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $134,799 | FY2026 |
| 36C24926N0641 | DIASORIN INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $172,138 | FY2026 |
| 36C24926P0473 | TERUMO BCT BIOTECHNOLOGIES, LLC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $16,420 | FY2026 |
| 36C24926P0421 | CREATIVE WASTE SOLUTIONS, INC | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $35,433 | FY2026 |
| 36C24926P0425 | STRIPES GLOBAL, INC. | 249-NETWORK CONTRACT OFFICE 9 (36C249) | $23,000 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24922N0053_3600_V797D70110_3600 · retrieved 2026-09-26.